Tech Company Inital Public Offerings
Biomea Fusion IPO
Biomea Fusion, operating out of Redwood City, offered its shares in an initial public offering on 4/20/2021.
Transaction Overview
Company Name
Announced On
4/20/2021
Transaction Type
IPO
Amount
$153,000,000
Proceeds Purpose
We currently intend to use the net proceeds from this offering, together with our existing cash and cash equivalents, as follows: to fund our ongoing IND-enabling studies and planned Phase 1/2 clinical trial of BMF-219; to fund our research and development efforts with respect to our two undisclosed programs; and the remainder, if any, for working capital and other general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
726 Main St. Chamberlain Building
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
We are a precision oncology company developing novel small molecules that target aggressive forms of cancer. Patients with these aggressive tumors typically exhibit high mortality rates and suffer from inadequate treatment options. We are dedicated to developing innovative medicines for patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Butler
Chief Information Officer
Anthony Souza
President
Ramses Erdtmann
Vice President
Taisei Kinoshita
Vice President
Thorsten Kirschberg
VP - Finance
Sunny Ryan
VP - Operations
Naomi Cretcher
Browse more venture capital transactions:
Prev: 4/20/2021: Hungry Planet venture capital transaction
Next: 4/20/2021: Knox Financial venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs